🇰🇷 Librax in South Korea

Librax (CLIDINIUM) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Marketing authorisation holder: ROCHE
  • Status: likely_approved

Librax in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in South Korea

Frequently asked questions

Is Librax approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Librax in South Korea?

ROCHE holds the South Korean marketing authorisation.